$AMGN Company News Nasdaq breaks out, reaches
Post# of 89400
Posted On: 08/21/2014 11:49:38 AM
$AMGN Company News
Nasdaq breaks out, reaches less-charted territory 12:05 p.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:56 a.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:44 a.m. Aug. 19, 2014 - Michael Ashbaugh
Berkshire Hathaway tops $200,000; Cisco drops on results 12:19 p.m. Aug. 14, 2014 - Angela Johnson
Cisco volatile after hours in wake of earnings 5:03 p.m. Aug. 13, 2014 - Sue Chang
Amgen recalls syringes of anemia drug Aranesp 4:55 p.m. Aug. 13, 2014 - Russ Britt
CORRECT: Amgen shares fall after-hours on disappointing trial data 4:34 p.m. Aug. 13, 2014 - Tomi Kilgore
U.S. stocks rally; Dow snaps 4-session losing streak 4:14 p.m. Aug. 4, 2014 - Barbara Kollmeyer
Mobileye rises for second day; Michael Kors falls 1:23 p.m. Aug. 4, 2014 - Angela Johnson
Amgen shares rally 2.7% to top S&P 500 9:30 a.m. Aug. 4, 2014 - Sue Chang
Amgen reports successful late-stage trial of cancer treatment 8:34 a.m. Aug. 4, 2014 - Joshua Jamerson
Amgen reports positive trial of multiple myeloma treatment 7:49 a.m. Aug. 4, 2014 - Ciara Linnane
Tesla Shares Weaken in After Hours 8:13 p.m. July 31, 2014 - MarketWatch
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - blogs.marketwatch.com
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - MarketWatch
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - blogs.marketwatch.com
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - blogs.marketwatch.com
Twitter shines; Fed statement and GDP due today 4:38 a.m. July 30, 2014 - MarketWatch
Amgen plans to cut up to 2,900 jobs 9:04 p.m. July 29, 2014 - MarketWatch.com
Twitter soars 33% in after hours as results surprise on upside 4:56 p.m. July 29, 2014 - Sue Chang
Lilly psoriasis mAb successful in Phase 3 trial 30 min ago - Seeking Alpha
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog 4:27 p.m. Aug. 20, 2014 - Zacks.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog 11:08 a.m. Aug. 20, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: AXP, AMGN, USB 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog 5:25 p.m. Aug. 19, 2014 - Zacks.com
Right on Target 1:33 p.m. Aug. 19, 2014 - Barrons.com
3 Stocks Pulling The Health Care Sector Downward 1:03 p.m. Aug. 19, 2014 - TheStreet.com
Amgen's thyroid drug meets Phase 3 endpoints 5:51 p.m. Aug. 18, 2014 - Seeking Alpha
Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog 5:10 p.m. Aug. 18, 2014 - Zacks.com
Amgen (AMGN) Hits New Lifetime High Today 9:45 a.m. Aug. 18, 2014 - TheStreet.com
RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now 8:27 a.m. Aug. 18, 2014 - 247WallSt.com
Biotech Stock Mailbag: Exact Sciences, Galena, Amgen 7:22 a.m. Aug. 15, 2014 - TheStreet.com
Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog 5:20 p.m. Aug. 14, 2014 - Zacks.com
Today's Market: Biotech And Technology Names Moving On News 1:33 p.m. Aug. 14, 2014 - Seeking Alpha
Trade-Ideas: Amgen (AMGN) Is Today's "Barbarian At The Gate" Stock 11:17 a.m. Aug. 14, 2014 - TheStreet.com
Amgen Cancer Drug Kyprolis Fails Trial 6:31 p.m. Aug. 13, 2014 - The Wall Street Journal Interactive Edition
Amgen cancer drug fails Phase 3 trial 5:54 p.m. Aug. 13, 2014 - Seeking Alpha
Amgen recalls certain lots of Aranesp 5:38 p.m. Aug. 13, 2014 - Seeking Alpha
After-Hours Trading Shows Amgen (AMGN) Lagging 4:18 p.m. Aug. 13, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: CAT, BIIB, AMGN 10:29 a.m. Aug. 13, 2014 - TheStreet.com
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
A New Cannabinoid-based Arthritis Therapy in the Making 9:50 a.m. Aug. 19, 2014 - ACCESSWIRE
Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 1:55 a.m. Aug. 19, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis 5:17 p.m. Aug. 18, 2014 - PR Newswire - PRF
Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy 9:15 a.m. Aug. 14, 2014 - PR Newswire - PRF
Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates 4:12 p.m. Aug. 13, 2014 - PR Newswire - PRF
Amgen Announces Top-Line Results From Phase 3 Focus Trial Of Kyprolis® In Patients With Relapsed And Advanced Refractory Multiple Myeloma 4:01 p.m. Aug. 13, 2014 - PR Newswire - PRF
Investors Applaud Amgen and Novartis for Support of Investor Principles on Biosimilars, Alternatives to Higher Cost Drugs 1:07 p.m. Aug. 11, 2014 - PR Newswire - PRF
Amgen Receives CEO Cancer Gold Standard Accreditation 7:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Ophthalmic Drugs Market Forecast 2014-2024: Prospects for Leading Companies 11:55 a.m. Aug. 4, 2014 - PR Newswire - PRF
Earnings Headlines - Amgen 9:30 a.m. Aug. 4, 2014 - PR Newswire - PRF
Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint 7:30 a.m. Aug. 4, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain 10:00 a.m. July 30, 2014 - Marketwire
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Amgen Announces 2014 Third Quarter Dividend 4:00 p.m. July 25, 2014 - PR Newswire - PRF
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer 2:30 a.m. July 25, 2014 - PR Newswire - PRF
Nasdaq breaks out, reaches less-charted territory 12:05 p.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:56 a.m. Aug. 19, 2014 - Michael Ashbaugh
Nasdaq breaks out, reaches less-charted territory 11:44 a.m. Aug. 19, 2014 - Michael Ashbaugh
Berkshire Hathaway tops $200,000; Cisco drops on results 12:19 p.m. Aug. 14, 2014 - Angela Johnson
Cisco volatile after hours in wake of earnings 5:03 p.m. Aug. 13, 2014 - Sue Chang
Amgen recalls syringes of anemia drug Aranesp 4:55 p.m. Aug. 13, 2014 - Russ Britt
CORRECT: Amgen shares fall after-hours on disappointing trial data 4:34 p.m. Aug. 13, 2014 - Tomi Kilgore
U.S. stocks rally; Dow snaps 4-session losing streak 4:14 p.m. Aug. 4, 2014 - Barbara Kollmeyer
Mobileye rises for second day; Michael Kors falls 1:23 p.m. Aug. 4, 2014 - Angela Johnson
Amgen shares rally 2.7% to top S&P 500 9:30 a.m. Aug. 4, 2014 - Sue Chang
Amgen reports successful late-stage trial of cancer treatment 8:34 a.m. Aug. 4, 2014 - Joshua Jamerson
Amgen reports positive trial of multiple myeloma treatment 7:49 a.m. Aug. 4, 2014 - Ciara Linnane
Tesla Shares Weaken in After Hours 8:13 p.m. July 31, 2014 - MarketWatch
Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - blogs.marketwatch.com
Twitter, U.S. Steel soar; Buffalo Wild Wings are burned 4:26 p.m. July 30, 2014 - MarketWatch
Edwards, Hospira rise as health-care companies see strong earnings 1:08 p.m. July 30, 2014 - blogs.marketwatch.com
Amgen shares hit record on cost-cutting plans 10:50 a.m. July 30, 2014 - blogs.marketwatch.com
Twitter shines; Fed statement and GDP due today 4:38 a.m. July 30, 2014 - MarketWatch
Amgen plans to cut up to 2,900 jobs 9:04 p.m. July 29, 2014 - MarketWatch.com
Twitter soars 33% in after hours as results surprise on upside 4:56 p.m. July 29, 2014 - Sue Chang
Lilly psoriasis mAb successful in Phase 3 trial 30 min ago - Seeking Alpha
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog 4:27 p.m. Aug. 20, 2014 - Zacks.com
Biotech Stock Roundup: Achillion Scores in Mid-Stage Study, Gilead's Sovaldi Remains in Focus - Analyst Blog 11:08 a.m. Aug. 20, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: AXP, AMGN, USB 10:29 a.m. Aug. 20, 2014 - TheStreet.com
Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog 5:25 p.m. Aug. 19, 2014 - Zacks.com
Right on Target 1:33 p.m. Aug. 19, 2014 - Barrons.com
3 Stocks Pulling The Health Care Sector Downward 1:03 p.m. Aug. 19, 2014 - TheStreet.com
Amgen's thyroid drug meets Phase 3 endpoints 5:51 p.m. Aug. 18, 2014 - Seeking Alpha
Ligand Up on Multi-Program Captisol Deal with Avion Pharma - Analyst Blog 5:10 p.m. Aug. 18, 2014 - Zacks.com
Amgen (AMGN) Hits New Lifetime High Today 9:45 a.m. Aug. 18, 2014 - TheStreet.com
RBC’s Top Quintile Quantitative Portfolio Stocks to Buy Now 8:27 a.m. Aug. 18, 2014 - 247WallSt.com
Biotech Stock Mailbag: Exact Sciences, Galena, Amgen 7:22 a.m. Aug. 15, 2014 - TheStreet.com
Amgen's FOCUS Study on Multiple Myeloma Drug Kyprolis Fails - Analyst Blog 5:20 p.m. Aug. 14, 2014 - Zacks.com
Today's Market: Biotech And Technology Names Moving On News 1:33 p.m. Aug. 14, 2014 - Seeking Alpha
Trade-Ideas: Amgen (AMGN) Is Today's "Barbarian At The Gate" Stock 11:17 a.m. Aug. 14, 2014 - TheStreet.com
Amgen Cancer Drug Kyprolis Fails Trial 6:31 p.m. Aug. 13, 2014 - The Wall Street Journal Interactive Edition
Amgen cancer drug fails Phase 3 trial 5:54 p.m. Aug. 13, 2014 - Seeking Alpha
Amgen recalls certain lots of Aranesp 5:38 p.m. Aug. 13, 2014 - Seeking Alpha
After-Hours Trading Shows Amgen (AMGN) Lagging 4:18 p.m. Aug. 13, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: CAT, BIIB, AMGN 10:29 a.m. Aug. 13, 2014 - TheStreet.com
Drug Approvals, Clinical Trial Result, and Philanthropic Activity - Research Reports on Johnson & Johnson, Biogen, Amgen, Medtronic and Merck 9:20 a.m. Aug. 20, 2014 - PR Newswire - PRF
A New Cannabinoid-based Arthritis Therapy in the Making 9:50 a.m. Aug. 19, 2014 - ACCESSWIRE
Gamida Cell Announces Investment and Option Agreement with Major Pharmaceutical Company 1:55 a.m. Aug. 19, 2014 - PR Newswire - PRF
Amgen Announces Positive Top-Line Results From Second Phase 3 Study Of AMG 416 For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease Receiving Hemodialysis 5:17 p.m. Aug. 18, 2014 - PR Newswire - PRF
Lemelson Capital Says Ligand Pharmaceuticals' $225M Debt Issuance Solidifies Company's Insolvency, Substantially Raises Specter of Bankruptcy 9:15 a.m. Aug. 14, 2014 - PR Newswire - PRF
Amgen Issues Voluntary Recall of Aranesp® (darbepoetin alfa) (500 mcg) Prefilled Syringes in Several Countries Outside of the United States Due to the Presence of Visible Particulates 4:12 p.m. Aug. 13, 2014 - PR Newswire - PRF
Amgen Announces Top-Line Results From Phase 3 Focus Trial Of Kyprolis® In Patients With Relapsed And Advanced Refractory Multiple Myeloma 4:01 p.m. Aug. 13, 2014 - PR Newswire - PRF
Investors Applaud Amgen and Novartis for Support of Investor Principles on Biosimilars, Alternatives to Higher Cost Drugs 1:07 p.m. Aug. 11, 2014 - PR Newswire - PRF
Amgen Receives CEO Cancer Gold Standard Accreditation 7:00 a.m. Aug. 11, 2014 - BusinessWire - BZX
Critical Alerts For Stratasys, Horizon Pharma, Isis Pharmaceuticals, Amgen, and Discover Financial Services Released By InvestorsObserver 9:31 a.m. Aug. 8, 2014 - PR Newswire - PRF
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth 9:13 a.m. Aug. 5, 2014 - PR Newswire - PRF
Ophthalmic Drugs Market Forecast 2014-2024: Prospects for Leading Companies 11:55 a.m. Aug. 4, 2014 - PR Newswire - PRF
Earnings Headlines - Amgen 9:30 a.m. Aug. 4, 2014 - PR Newswire - PRF
Drug Approvals and Earnings Releases - Research Reports on Bristol-Myers, Johnson & Johnson, Merck, Pharmacyclics and Amgen 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Amgen Announces Phase 3 ASPIRE Trial Of Kyprolis® In Patients With Relapsed Multiple Myeloma Met Primary Endpoint 7:30 a.m. Aug. 4, 2014 - PR Newswire - PRF
RBCC 3D Bioprinting Partner Awarded Prestigious Grant 6:54 a.m. July 31, 2014 - BusinessWire - BZX
Resilinc Named 2014 Great Supply Chain Partner by SupplyChainBrain 10:00 a.m. July 30, 2014 - Marketwire
Global Women%s Health Market 2014-2018 6:20 p.m. July 28, 2014 - PR Newswire - PRF
Amgen Announces 2014 Third Quarter Dividend 4:00 p.m. July 25, 2014 - PR Newswire - PRF
Bayer and Onyx Pharmaceuticals Report Phase 3 Trial Results of NEXAVAR® (sorafenib) in Patients with Advanced Breast Cancer 2:30 a.m. July 25, 2014 - PR Newswire - PRF
(0)
(0)